Covered recipient · General Payments record
JON NICHOLS
General Payments · PY2018–2024
$2,211.24
- Reported across 138 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $552.52 | 34 |
| Education | $17.03 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $288.81 | 20 |
| PFIZER INC. | $48.09 | 3 |
| Novo Nordisk AS | $45.38 | 2 |
| Ardelyx, Inc. | $39.60 | 2 |
| Celltrion USA Inc. | $35.27 | 2 |
| GENZYME CORPORATION | $30.55 | 1 |
| Merck Sharp & Dohme Corporation | $30.03 | 2 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $19.35 | 1 |
| Celgene Corporation | $16.28 | 1 |
| INTERCEPT PHARMACEUTICALS, INC. | $16.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.21 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105124253 | CMS |
| ABBVIE INC. | $11.33 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105124255 | CMS |
| ABBVIE INC. | $14.23 | 02/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105124257 | CMS |
| ABBVIE INC. | $14.07 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105124259 | CMS |
| ABBVIE INC. | $5.92 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105124261 | CMS |
| ABBVIE INC. | $16.84 | 03/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105124263 | CMS |
| ABBVIE INC. | $15.41 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105124265 | CMS |
| ABBVIE INC. | $18.39 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105124267 | CMS |
| ABBVIE INC. | $15.36 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105124269 | CMS |
| ABBVIE INC. | $13.91 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105124271 | CMS |
| ABBVIE INC. | $16.05 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105124273 | CMS |
| ABBVIE INC. | $18.14 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105124275 | CMS |
| ABBVIE INC. | $13.77 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105124277 | CMS |
| ABBVIE INC. | $13.72 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105124279 | CMS |
| ABBVIE INC. | $12.98 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105124281 | CMS |
| ABBVIE INC. | $13.15 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105124283 | CMS |
| ABBVIE INC. | $9.12 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105124285 | CMS |
| ABBVIE INC. | $18.82 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105124287 | CMS |
| ABBVIE INC. | $17.54 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105124289 | CMS |
| ABBVIE INC. | $14.85 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105124291 | CMS |
| Ardelyx, Inc. | $18.91 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146698014 | CMS |
| Ardelyx, Inc. | $20.69 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146698016 | CMS |
| Celgene Corporation | $16.28 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101125012 | CMS |
| Celltrion USA Inc. | $17.03 | 04/30/2024 | Education | Undisputed | 01/23/2026 | 1075855981 | CMS |
| Celltrion USA Inc. | $18.24 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1075855983 | CMS |
| GENZYME CORPORATION | $30.55 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139958095 | CMS |
| Intercept Pharmaceuticals, Inc. | $16.19 | 08/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113635720 | CMS |
| Merck Sharp & Dohme LLC | $13.35 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141781061 | CMS |
| Merck Sharp & Dohme LLC | $16.68 | 07/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141781059 | CMS |
| Novo Nordisk Inc | $22.45 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108578741 | CMS |
| Novo Nordisk Inc | $22.93 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108574128 | CMS |
| PFIZER INC. | $18.63 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130929947 | CMS |
| PFIZER INC. | $15.72 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130957613 | CMS |
| PFIZER INC. | $13.74 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131487817 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $19.35 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153604645 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.